(Total Views: 340)
Posted On: 10/18/2018 5:37:23 PM
Post# of 721
NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Granted Two New US Patents
Drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) this morning announced that it has been granted two new U.S. patents. Per the update, the two new patents are related to certain cannabinoid infused beverage compositions utilizing Lexaria’s proprietary DehydraTECH process, a process which continues to strengthen the company’s dominant intellectual property position in the growing cannabis beverage market. With these new additions, Lexaria now has six granted patents in the U.S. and four granted patents in Australia, all 10 of which fall within the company’s first patent family, “Food and Beverage Compositions Infused With Lipophilic Active Agents and Methods of Use Thereof.” Lexaria is currently pursuing accelerated examination for patent applications in Australia based on these newest U.S. patents and hopes to receive two corresponding Australian patents by the end of 2018.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) this morning announced that it has been granted two new U.S. patents. Per the update, the two new patents are related to certain cannabinoid infused beverage compositions utilizing Lexaria’s proprietary DehydraTECH process, a process which continues to strengthen the company’s dominant intellectual property position in the growing cannabis beverage market. With these new additions, Lexaria now has six granted patents in the U.S. and four granted patents in Australia, all 10 of which fall within the company’s first patent family, “Food and Beverage Compositions Infused With Lipophilic Active Agents and Methods of Use Thereof.” Lexaria is currently pursuing accelerated examination for patent applications in Australia based on these newest U.S. patents and hopes to receive two corresponding Australian patents by the end of 2018.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
